Trademark: ELZONRIS
Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io
Mark Identification
Proof of use for ELZONRIS
We do not have any records of a proof of use for ELZONRIS at this moment.
Possible trademark infringements of ELZONRIS
Basic Information about ELZONRIS
- Serial Number
- 87843152
- Filing Date
- 21 Mar 2018
- Registration Number
- 5782895
- Registration Date
- 18 Jun 2019
- Mark Drawing Code
- 4
Classifications
Declare the trademark use of ELZONRIS on the blockchain with WikiTrademarks.io.
- First use of ELZONRIS anywhere
- ELZONRIS was first used on 23 Jan 2019 for the primary classification of goods and services, international, 005 (Pharmaceuticals)
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 005
- US Codes
- 006; 018; 044; 046; 051; 052
Who owns ELZONRIS?
1. Stemline Therapeutics, Inc. New York NY
2. Stemline Therapeutics, Inc. New York NY
3. Stemline Therapeutics, Inc. New York NY
Correspondent
- Maury M. Tepper, III
- Tepper & Eyster, PLLC
- 3724 Benson Drive
- Raleigh, NC 27609
Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io